The specific activity of CAMP-dependent protein kinase was studied during the differentiation of 3T3-Ll fibroblasts into adipocytes.8-Azido-adenosine 3':5'monophosphate, a photoaffinity-labeling analogue of CAMP, was used to quantitate the regulatory subunits of the type I and type 11 CAMP-dependent protein kinase in cell extracts.The catalytic subunit of CAMP-dependent protein kinase was studied by assaying for CAMPdependent histone kinase activity.A significant increase in CAMP-dependent protein kinase activity was observed during the adipose development of 3T3-Ll cells, promoted by 3-isobutyl-1-methylxanthine (IBMX), dexamethasone, and insulin.This increase was attributed primarily to a 3-to 6-fold increase in the type I CAMP-dependent protein kinase, as demonstrated either by the incorporation of 8-azidoadenosine 3':5'-monophosphate into the 47,000-dalton regulatory subunit of the type I kinase or by the separation and analysis of the type I and type I1 kinases through DEAE-Sephacel column chromatography.The time course of increase in the type I CAMP-dependent protein kinase preceded increases both in malic enzyme and glutamine synthetase activities and was maximal at 5 days after initiation of the hormone treatment.The induction of CAMP-dependent protein kinase does not appear to involve an increase in intracellular CAMP.The addition of either 1 m~ dibutyryl CAMP or 0.5 m~ IBMX had little or no effect on the expression of CAMP-dependent protein kinase activity in the 3T3-Ll cells, although a marked increase in CAMP phosphodiesterase activity was observed in cells treated with dibutyryl CAMP.
No takes yet. Share an insight, caveat, or question.
Alice Y.‐C. Liu (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: